A Pilot Study Evaluating the Effects of Diabetes Specific Nutrition Supplement and Lifestyle Intervention on Glycemic Control in Overweight and Obese Asian Indian Adults with Type 2 Diabetes Mellitus.

Plain-language guide to PMID 31801326 (2019): randomized and pilot clinical trial of Copper (Supplement) in 120 individuals.

Key Facts

PMID: 31801326
Journal: The Journal of the Association of Physicians of India
Year: 2019
Study type: Clinical Trial
Authors: Mohan V et al. (10 authors)

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Copper (Supplement), published as a clinical trial.

Medical nutrition therapy plays a crucial role achievement of optimal glycemic control in individuals with diabetes.

This study aims to evaluate the effects of diabetes specific nutrition supplement (DSNS) along with lifestyle intervention in overweight and obese adults with Type 2 Diabetes Mellitus (T2DM).

Who Took Part

According to the abstract, 120 individuals were involved.

PubMed indexes the participants as adults, middle-aged adults and older adults.

All participants received dietary counselling with diet chart of 1400 kcal/day and recommendations for physical activity.

How the Study Was Run

The design is described as randomized and pilot.

Random assignment meant chance, not the researchers, decided who got Copper (Supplement) and who got the comparison, which limits bias.

It is described as a pilot, a small early test of whether a larger Copper (Supplement) study would be practical.

A total of 120 overweight or obese individuals aged 30 - 65 years with T2DM, were randomly allocated to intervention (IG, n=60) and control (CG, n=60) groups in this 12-week study.

Continuous glucose monitoring was performed during the initial 2 weeks and last 2 weeks of the study in a sub- sample using Flash Glucose Monitoring device to study glycemic excursions.

Data was analyzed for the differences between intervention vs. control group using linear models.

What Was Measured

Topics PubMed links to this paper include Asian People, Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 2, Glycated Hemoglobin, Life Style and Obesity.

What This Means in Plain Language

The paper is a randomized and pilot study of Copper (Supplement) in 120 individuals.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2019 (The Journal of the Association of Physicians of India), a journal based in India.

More context: the Copper (Supplement) compound page, all human trials.

Our Notes on the Compound

Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.

Copper (Supplement) in the library

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.